The University of Chicago Header Logo

Connection

Mark Talamonti to Survival Analysis

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Survival Analysis.
Mark Talamonti
Connection Strength
0.779
Survival Analysis
  1. Quality of pancreatic cancer care at Veterans Administration compared with non-Veterans Administration hospitals. Am J Surg. 2007 Nov; 194(5):588-93.
    View in: PubMed
    Score: 0.059
  2. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume. Cancer. 2007 Sep 15; 110(6):1227-34.
    View in: PubMed
    Score: 0.059
  3. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer. 2007 Aug 15; 110(4):738-44.
    View in: PubMed
    Score: 0.059
  4. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg. 2007 Oct; 205(4):558-63.
    View in: PubMed
    Score: 0.058
  5. Guidelines for the surgical management of pancreatic adenocarcinoma. Semin Oncol. 2007 Aug; 34(4):311-20.
    View in: PubMed
    Score: 0.058
  6. Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg. 2007 Mar; 193(3):389-93; discussion 393-4.
    View in: PubMed
    Score: 0.057
  7. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s. Cancer Invest. 2004; 22(2):225-33.
    View in: PubMed
    Score: 0.046
  8. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003 Oct; 134(4):720-7; discussion 727-9.
    View in: PubMed
    Score: 0.045
  9. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg. 2002 May; 137(5):564-70; discussion 570-1.
    View in: PubMed
    Score: 0.041
  10. Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J Clin Oncol. 2000 Oct 01; 18(19):3384-9.
    View in: PubMed
    Score: 0.036
  11. Orthotopic liver transplantation provides a survival advantage compared with resection in patients with hepatocellular carcinoma and preserved liver function. Surgery. 2017 11; 162(5):1032-1039.
    View in: PubMed
    Score: 0.029
  12. A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer. J Gastrointest Surg. 2016 Feb; 20(2):284-92.
    View in: PubMed
    Score: 0.026
  13. Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2014 Dec; 156(6):1504-10; discussion 1510-1.
    View in: PubMed
    Score: 0.024
  14. Locally advanced carcinoma of the colon and rectum involving the urinary bladder. Surg Gynecol Obstet. 1993 Nov; 177(5):481-7.
    View in: PubMed
    Score: 0.023
  15. Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study. J Gastrointest Surg. 2013 Jan; 17(1):94-100; discussion p. 100-1.
    View in: PubMed
    Score: 0.021
  16. A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma. PLoS Med. 2010 Jul 13; 7(7):e1000307.
    View in: PubMed
    Score: 0.018
  17. Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma. J Surg Oncol. 2010 Jun 01; 101(7):587-92.
    View in: PubMed
    Score: 0.018
  18. Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? J Gastrointest Surg. 2009 Sep; 13(9):1692-8.
    View in: PubMed
    Score: 0.017
  19. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer. 2009 May 01; 115(9):1849-58.
    View in: PubMed
    Score: 0.016
  20. Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol. 2008 Oct 01; 26(28):4626-33.
    View in: PubMed
    Score: 0.016
  21. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. Radiology. 2008 May; 247(2):507-15.
    View in: PubMed
    Score: 0.015
  22. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol. 2008 Feb 20; 26(6):942-7.
    View in: PubMed
    Score: 0.015
  23. Primary gastrointestinal sarcomas: analysis of prognostic factors and results of surgical management. Surgery. 2000 Oct; 128(4):604-12.
    View in: PubMed
    Score: 0.009
  24. Results of gastric interposition for reconstruction of the pharyngoesophagus. Surgery. 1999 Oct; 126(4):666-71; discussion 671-2.
    View in: PubMed
    Score: 0.008
  25. Cystic neoplasms of the pancreas. A clinicopathologic study, including DNA flow cytometry. Arch Surg. 1995 Oct; 130(10):1048-54.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.